Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
China · Delayed Price · Currency is CNY 20.31
+0.26 (1.30%)
At close: Jun 18, 2026
SHE:001367 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | 133.58 | 135.88 | 122.56 | 104.67 | 107.59 | 94 |
Depreciation & Amortization | 23.18 | 23.18 | 16.79 | 13.41 | 14.3 | 13.03 |
Other Amortization | 0.85 | 0.85 | 0.49 | 1.99 | 1.68 | 1.71 |
Loss (Gain) From Sale of Assets | - | - | - | 0.24 | - | - |
Asset Writedown & Restructuring Costs | 0.4 | 0.4 | 1.23 | 0.96 | 1.21 | 0.67 |
Loss (Gain) From Sale of Investments | -6.71 | -6.71 | -3 | -0.32 | 3.85 | -1.45 |
Provision & Write-off of Bad Debts | 2.73 | 2.73 | 0.09 | 0.43 | 1.09 | -0.27 |
Other Operating Activities | -10.75 | 1.12 | 0.6 | 1.6 | -7.45 | 4.29 |
Change in Accounts Receivable | -16.48 | -16.48 | -27.23 | -20.56 | 11.11 | -22.35 |
Change in Inventory | -3.05 | -3.05 | 37.64 | -19.1 | -38.88 | -20.63 |
Change in Accounts Payable | 17.17 | 17.17 | 11.19 | -4.6 | -19.29 | 36.22 |
Change in Other Net Operating Assets | 20.71 | 20.71 | 5.77 | -0.08 | 0.22 | -0.24 |
Operating Cash Flow | 163.28 | 177.45 | 167.16 | 80.62 | 74.95 | 107.04 |
Operating Cash Flow Growth | -12.23% | 6.16% | 107.35% | 7.56% | -29.98% | 39.93% |
Capital Expenditures | -114.38 | -152.26 | -64.75 | -57.44 | -20.19 | -33.32 |
Sale of Property, Plant & Equipment | - | - | - | 0.12 | - | 0 |
Investment in Securities | -92.23 | -144.98 | 3 | 0.32 | -0.99 | -1.21 |
Investing Cash Flow | -206.61 | -297.25 | -61.75 | -57 | -21.18 | -34.52 |
Long-Term Debt Repaid | - | -1.72 | -1.86 | -1.04 | -1.15 | -0.88 |
Total Debt Repaid | -1.72 | -1.72 | -1.86 | -1.04 | -1.15 | -0.88 |
Net Debt Issued (Repaid) | -1.72 | -1.72 | -1.86 | -1.04 | -1.15 | -0.88 |
Issuance of Common Stock | 3.58 | 3.58 | 25.46 | 698.45 | - | - |
Common Dividends Paid | -17.45 | -17.45 | -34 | - | -0.71 | -16.43 |
Other Financing Activities | - | - | - | -24.08 | -1.9 | -1.4 |
Financing Cash Flow | -15.59 | -15.59 | -10.39 | 673.33 | -3.77 | -18.71 |
Foreign Exchange Rate Adjustments | -0.38 | 0.91 | 2.68 | 0.61 | 5.52 | -1.46 |
Net Cash Flow | -59.3 | -134.47 | 97.69 | 697.55 | 55.52 | 52.35 |
Free Cash Flow | 48.9 | 25.19 | 102.41 | 23.17 | 54.76 | 73.72 |
Free Cash Flow Growth | -45.01% | -75.40% | 341.91% | -57.68% | -25.73% | 32.89% |
Free Cash Flow Margin | 9.38% | 4.73% | 21.72% | 5.83% | 12.95% | 18.95% |
Free Cash Flow Per Share | 0.32 | 0.17 | 0.69 | 0.17 | 0.49 | 0.66 |
Cash Income Tax Paid | 7.19 | 8.93 | 19.27 | 33.38 | 5.24 | 12.89 |
Levered Free Cash Flow | 1.28 | -21.2 | 83.57 | -18.14 | -2.35 | 44.27 |
Unlevered Free Cash Flow | 1.49 | -20.98 | 83.8 | -18.12 | -2.31 | 44.34 |
Change in Working Capital | 20.01 | 20.01 | 28.39 | -42.36 | -47.31 | -4.94 |